Indeed, survival analysis of a The Cancer Genome Atlas dataset of CRC patients revealed no difference in overall survival between LDLR high and low expression groups (data not shown), indicating that LDLR expression in the gut per se is unlikely a major determinant of CRC prognosis. This evidence concerns the gene LDLR and colorectal carcinoma.